Clinical Trials
All Clinical Trials - Page 43 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06133946N/AActive Not Recruiting
Cohort Of DEafness-gene Screening
MOTS-c
- NCT02621736N/ACompleted
Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).
Desmopressin
- NCT02545751Phase 2Unknown
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Thymosin-Alpha-1
- NCT02542930Phase 2Withdrawn
Abscopal Effect for Metastatic Non-small Cell Lung Cancer.
Thymosin-Alpha-1
- NCT02635607N/AUnknown
Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol
Gonadorelin
- NCT02626507Phase 1Unknown
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Gonadorelin
- NCT03134690N/ACompleted
GnRh Antagonist Protocol With Delayed Start Stimulation in Patients With Poor Ovarian Response
Gonadorelin
- NCT03006406N/AUnknown
Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embryo Transfer in Patients With Endometriosis
Gonadorelin
- NCT02832999Phase 4Completed
Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
Liraglutide
- NCT02650596N/AUnknown
Effects of GLP-1 on Chronic Heart Failure
Liraglutide
- NCT02650479Phase 1Completed
Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
Exenatide
- NCT02597777N/ACompleted
Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin
Argireline
- NCT02698384N/ATerminated
Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg
Lanreotide
- NCT02607293N/ACompleted
A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
Gonadorelin
- NCT02430103N/AActive Not Recruiting
Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients
Gonadorelin
- NCT02647944Phase 2Completed
Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
Liraglutide
- NCT02651987Phase 2Completed
Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg
Lanreotide
- NCT02655146Phase 4Unknown
the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .
Gonadorelin
- NCT02638805Phase 3Completed
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Liraglutide
- NCT02611232Phase 2Unknown
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
Liraglutide
- NCT02621489Phase 4Completed
Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
Exenatide
- NCT02641899Phase 1Completed
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
Exenatide
- NCT02641990Phase 1Completed
Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects
Exenatide
- NCT02496611Phase 2Completed
Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
Exenatide
- NCT02656810Phase 1Completed
A Comparison Study of PF708 and Forteo in Healthy Subjects
Teriparatide
- NCT02431325Phase 2Completed
A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV
Teduglutide
- NCT02489318Phase 3Active Not Recruiting
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
Gonadorelin
- NCT02730104N/ACompleted
Community-based Neuroendocrine Tumor (NET) Research Study
Lanreotide
- NCT02531516Phase 3Active Not Recruiting
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Gonadorelin
- NCT02602600Phase 4Completed
Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
Liraglutide
- NCT02607306Phase 3Completed
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
Liraglutide
- NCT03889496N/ATerminated
Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
Exenatide
- NCT02278185Phase 2Completed
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
Gonadorelin
- NCT02443155Phase 2Completed
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
Liraglutide
- NCT02527200Phase 3Completed
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
Liraglutide
- NCT02559570Phase 2Completed
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Linaclotide
- NCT03162042N/ACompleted
Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers
Follistatin
- NCT03534310N/ACompleted
Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
Liraglutide
- NCT02590432Phase 4Completed
An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Linaclotide
- NCT02559817Phase 2Terminated
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Linaclotide
- NCT02605226N/AUnknown
Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer
Gonadorelin
- NCT02357654Phase 4Recruiting
GnRH for Luteal Support in IVF/ICSI/FET Cycles
Gonadorelin
- NCT03010683N/ACompleted
Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
Liraglutide
- NCT02617654Phase 2Completed
Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
Liraglutide
- NCT02597049Phase 3Completed
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT02251431Phase 3Completed
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
Exenatide
- NCT02584075Phase 4Unknown
Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function
Exenatide
- NCT02449603Phase 4Completed
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
Exenatide
- NCT02563353N/ACompleted
PTH and Vibration in OSteoporosis Study
Teriparatide
- NCT02360384N/AUnknown
Caecal pH as a Biomarker for Irritable Bowel Syndrome
Linaclotide